Pharma Deals Review, Vol 2008, No 97 (2008)

Font Size:  Small  Medium  Large

Novartis Gains MRSA Product Through Acquisition of Protez Pharmaceuticals

Helen Scrutton

Abstract


Novartis gains a superbug-targeting antibiotic through this acquisition of Protez Pharmaceuticals.

Full Text: pdf html

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.